Skip NavigationSkip to Content

Activation and activities of the p53 tumour suppressor protein

  1. Author:
    Balint, E.
    Vousden, K. H.
  2. Author Address

    NCI Frederick, Bldg 560, Room 22-96, 1050 Boyles St, Frederick, MD 21702 USA. NCI Frederick, Frederick, MD 21702 USA. Balint E NCI Frederick, Bldg 560, Room 22-96, 1050 Boyles St, Frederick, MD 21702 USA.
    1. Year: 2001
  1. Journal: British Journal of Cancer
    1. 85
    2. 12
    3. Pages: 1813-1823
  2. Type of Article: Review
  1. Abstract:

    The p53 tumour suppressor protein inhibits malignant progression by mediating cell cycle arrest, apoptosis or repair following cellular stress. One of the major regulators of p53 function is the MDM2 protein, and multiple forms of cellular stress activate p53 by inhibiting the MDM2-mediated degradation of p53. Mutations in p53, or disruption of the pathways that allow activation of p53, seem to be a general feature of all cancers. Here we review recent advances in our understanding of the pathways that regulate p53 and the pathways that are induced by p53, as well as their implications for cancer therapy. (C) 2001 Cancer Research Campaign.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel